BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly ...

Coming up: Career Fair at Advocates on the Waltham Patch calendar ...

We just covered the 15 Safe Stocks to Invest In For Beginners and Pfizer Inc. (NYSE:PFE) ranks 14th on this list. Pfizer Inc.

Biotech investors spent much of the past year pulling back from speculative microcap names as higher rates, tighter capital ...

Eli Lilly (NYSE: LLY) is reportedly in talks to acquire cancer biotech Kelonia Therapeutics in a deal that could be worth ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The first three months of 2026 ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Bamboozled by Boolean operators? Wishing you could run and save literature searches, but not sure where to start? Attend the upcoming Informing Innovation Presents webinar on A Beginner's Guide to ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Biogen said Tuesday that ...

Novartis said it agreed to buy Excellergy for up to $2 billion, bulking up its immunology portfolio with a biotech company that specializes in treatments for food allergy and other diseases. The Swiss ...

An Allston mixed-use project has secured its first lab tenant since opening last year. King Street Properties' Allston LabWorks in Boston landed drug manufacturer Terrestrial Bio for a 42K SF lease, ...